{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:55:51Z","timestamp":1769090151180,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["90\/268"],"award-info":[{"award-number":["90\/268"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.intimp.2020.106704","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T13:17:37Z","timestamp":1592918257000},"page":"106704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The potential role of nicotinamide on Leishmania tropica: An assessment of inhibitory effect, cytokines gene expression and arginase profiling"],"prefix":"10.1016","volume":"86","author":[{"given":"Razieh Tavakoli","family":"Oliaee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Bamorovat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Keyhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Babaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Salarkia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahele","family":"Tavakoly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahshid","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.106704_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007092","article-title":"Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates","volume":"13","author":"Bailey","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.intimp.2020.106704_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2020.106704_b0015","first-page":"287","article-title":"Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014","volume":"91","author":"Organization","year":"2016","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.intimp.2020.106704_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007423","article-title":"Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran","volume":"13","author":"Aflatoonian","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.intimp.2020.106704_b0025","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/tmi.13062","article-title":"Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling","volume":"23","author":"Oliaee","year":"2018","journal-title":"Trop. Med. Int. Heal."},{"key":"10.1016\/j.intimp.2020.106704_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","article-title":"Leishmaniasis treatment\u2014a challenge that remains: a review","volume":"103","author":"Santos","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.intimp.2020.106704_b0035","unstructured":"Meeting WHOEC on the C of the L, Organization WH. In Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22\u201326 March 2010. World Health Organization; 2010."},{"key":"10.1016\/j.intimp.2020.106704_b0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.etap.2014.04.003","article-title":"Anti-leishmanial effect of itraconazole niosome on in vitro susceptibility of Leishmania tropica","volume":"38","author":"Khazaeli","year":"2014","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106704_b0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","article-title":"Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran","volume":"103","author":"Mohebali","year":"2007","journal-title":"Acta Trop."},{"key":"10.1016\/j.intimp.2020.106704_b0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/qjmed\/hct116","article-title":"Leishmaniasis: clinical syndromes and treatment","volume":"107","author":"McGwire","year":"2013","journal-title":"QJM An Int. J. Med."},{"key":"10.1016\/j.intimp.2020.106704_b0055","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/0140-6736(92)92952-C","article-title":"Amphotericin versus pentamidine in antimony-unresponsive kala-azar","volume":"340","author":"Mishra","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2020.106704_b0060","first-page":"365","article-title":"Antileishmanial activity of Peganum harmala extract on the in vitro growth of Leishmania major promastigotes in comparison to a trivalent antimony drug","volume":"77","author":"Mirzaie","year":"2007","journal-title":"Vet. Arh."},{"key":"10.1016\/j.intimp.2020.106704_b0065","article-title":"Evaluation of antileishmanial activity and cytotoxicity of the extracts of Berberis vulgaris and Nigella sativa against Leishmania tropica","volume":"51","author":"Mahmoudvand","year":"2014","journal-title":"J. Vector Borne Dis."},{"key":"10.1016\/j.intimp.2020.106704_b0070","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4103\/0972-9062.197271","article-title":"An in vitro study of antileishmanial effect of Portulaca oleracea extract","volume":"53","author":"Eskandari","year":"2016","journal-title":"J. Vector Borne Dis."},{"key":"10.1016\/j.intimp.2020.106704_b0075","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1086\/324161","article-title":"Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator","volume":"33","author":"Arevalo","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2020.106704_b0080","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archderm.142.12.1575","article-title":"Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial","volume":"142","author":"Firooz","year":"2006","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.intimp.2020.106704_b0085","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00436-011-2599-6","article-title":"The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate","volume":"110","author":"Shokri","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.intimp.2020.106704_b0090","series-title":"The vitamins: fundamental aspects in nutrition and health","author":"Combs","year":"2016"},{"key":"10.1016\/j.intimp.2020.106704_b0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","article-title":"NAD+ metabolism in health and disease","volume":"32","author":"Belenky","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.intimp.2020.106704_b0100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3727\/000000002783985710","article-title":"Enhanced in vitro maturation of fetal mouse liver cells with oncostatin M, nicotinamide, and dimethyl sulfoxide","volume":"11","author":"Sakai","year":"2002","journal-title":"Cell Transp."},{"key":"10.1016\/j.intimp.2020.106704_b0105","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.STR.31.7.1679","article-title":"Delayed Treatment With Nicotinamide (Vitamin B~ 3) Improves Neurological Outcome and Reduces Infarct Volume After Transient Focal Cerebral Ischemia in Wistar Rats","volume":"31","author":"Mokudai","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2020.106704_b0110","series-title":"Transplantation proceedings","first-page":"2021","article-title":"Nicotinamide induces both proliferation and differentiation of embryonic stem cells into insulin-producing cells","author":"Vaca","year":"2003"},{"key":"10.1016\/j.intimp.2020.106704_b0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/367544","article-title":"Nicotinamide: an oral antimicrobial agent with activity against both Mycobacterium tuberculosis and human immunodeficiency virus","volume":"36","author":"Murray","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2020.106704_b0120","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm.2175","article-title":"Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy","volume":"16","author":"Wurtele","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2020.106704_b0125","doi-asserted-by":"crossref","first-page":"10548","DOI":"10.1074\/jbc.M112.449207","article-title":"Nicotinamide inhibits the lysosomal cathepsin b-like protease and kills African trypanosomes","volume":"288","author":"Unciti-Broceta","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2020.106704_b0130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1574-6968.2008.01135.x","article-title":"Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth","volume":"282","author":"Prusty","year":"2008","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.intimp.2020.106704_b0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.parint.2010.09.005","article-title":"In vitro activity of nicotinamide\/antileishmanial drug combinations","volume":"60","author":"Gazanion","year":"2011","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.intimp.2020.106704_b0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.actatropica.2012.01.001","article-title":"Anti-Trypanosoma cruzi activity of nicotinamide","volume":"122","author":"Soares","year":"2012","journal-title":"Acta Trop."},{"key":"10.1016\/j.intimp.2020.106704_b0145","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1128\/AAC.49.2.808-812.2005","article-title":"In vitro antileishmanial activity of nicotinamide","volume":"49","author":"Sereno","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2020.106704_b0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-1119(02)00842-9","article-title":"Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death","volume":"296","author":"Vergnes","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.intimp.2020.106704_b0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2249.2003.02031.x","article-title":"Nicotinamide is a potent inhibitor of proinflammatory cytokines","volume":"131","author":"Ungerstedt","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2020.106704_b0160","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.3390\/molecules14093446","article-title":"The vitamin nicotinamide: translating nutrition into clinical care","volume":"14","author":"Maiese","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2020.106704_b0165","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fimmu.2012.00128","article-title":"Protective immunity and vaccination against cutaneous leishmaniasis","volume":"3","author":"Okwor","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2020.106704_b0170","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fimmu.2014.00532","article-title":"Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages","volume":"5","author":"Rath","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2020.106704_b0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/expr.2000.4537","article-title":"Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions","volume":"95","author":"Carrio","year":"2000","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.intimp.2020.106704_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-018-3354-1","article-title":"Homology modelling, molecular docking, and molecular dynamics simulations reveal the inhibition of Leishmania donovani dihydrofolate reductase-thymidylate synthase enzyme by Withaferin-A","volume":"11","author":"Vadloori","year":"2018","journal-title":"BMC Res Notes."},{"key":"10.1016\/j.intimp.2020.106704_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3347\/kjp.2019.57.1.1","article-title":"A Novel Niosomal Combination of Selenium Coupled with Glucantime against Leishmania tropica","volume":"57","author":"Mostafavi","year":"2019","journal-title":"Korean J. Parasitol."},{"key":"10.1016\/j.intimp.2020.106704_b0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.micpath.2018.12.040","article-title":"A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models","volume":"128","author":"Bamorovat","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2020.106704_b0195","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.micpath.2018.11.004","article-title":"Differential expression of TLRs 2, 4, 9, iNOS and TNF-\u03b1 and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica","volume":"126","author":"Oliaee","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2020.106704_b0200","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpddr.2017.06.003","article-title":"Antileishmanial activity and tubulin polymerization inhibition of podophyllotoxin derivatives on Leishmania infantum","volume":"7","author":"Escudero-Mart\u00ednez","year":"2017","journal-title":"Int J Parasitol Drugs Drug Resist."},{"key":"10.1016\/j.intimp.2020.106704_b0205","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2020.106704_b0210","unstructured":"Shirzadi MR, Gouya MM. National Guidelines for cutaneous leishmaniasis surveillance in Iran. Minist Heal Med Educ (MOH) Zoonoses Control Dep Tehran Iran; 2012, pp. 1\u201378."},{"key":"10.1016\/j.intimp.2020.106704_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: A 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.intimp.2020.106704_b0220","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0036-46652011000300003","article-title":"In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB\/c mice","volume":"53","author":"Mutiso","year":"2011","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.intimp.2020.106704_b0225","doi-asserted-by":"crossref","first-page":"214","DOI":"10.7555\/JBR.29.20140072","article-title":"In vitro activity and in vivo efficacy of a combination therapy of diminazene and chloroquine against murine visceral leishmaniasis","volume":"29","author":"Mwololo","year":"2015","journal-title":"J Biomed Res."},{"key":"10.1016\/j.intimp.2020.106704_b0230","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/656523","article-title":"Efficacy of topical liposomal amphotericin B versus intralesional meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis","volume":"2011","author":"Layegh","year":"2011","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.intimp.2020.106704_b0235","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF02252945","article-title":"The effect of niacinamide on osteoarthritis: a pilot study","volume":"45","author":"Jonas","year":"1996","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2020.106704_b0240","unstructured":"Maurice ES, James AO, Moshe S, A Catherine R. Modern Nutrition in Health and Disease 9th edition. OkDoKeY; 2019."},{"key":"10.1016\/j.intimp.2020.106704_b0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005590","article-title":"The mitochondrial SIR2 related protein 2 (SIR2RP2) impacts Leishmania donovani growth and infectivity","volume":"11","author":"Mittal","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.intimp.2020.106704_b0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0955-0674(03)00006-1","article-title":"Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease","volume":"15","author":"Lin","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.intimp.2020.106704_b0255","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.molcel.2005.02.022","article-title":"Mechanism of sirtuin inhibition by nicotinamide: altering the NAD+ cosubstrate specificity of a Sir2 enzyme","volume":"17","author":"Avalos","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2020.106704_b0260","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1158\/0008-5472.CAN-10-4452","article-title":"Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53\/miR-34a\/SIRT1 tumor suppressor network","volume":"71","author":"Audrito","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2020.106704_b0265","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","article-title":"Antagonistic crosstalk between NF-\u03baB and SIRT1 in the regulation of inflammation and metabolic disorders","volume":"25","author":"Kauppinen","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2020.106704_b0270","doi-asserted-by":"crossref","first-page":"45099","DOI":"10.1074\/jbc.M205670200","article-title":"Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1","volume":"277","author":"Bitterman","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2020.106704_b0275","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.exppara.2005.04.007","article-title":"Leishmania major and Leishmania tropica: I the in vitro effects of an immunomodulator, S2-Complex","volume":"111","author":"Hummadi","year":"2005","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.intimp.2020.106704_b0280","series-title":"Leishmania: Current Biology and Control","author":"Adak","year":"2015"},{"key":"10.1016\/j.intimp.2020.106704_b0285","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2020.106704_b0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005774","article-title":"Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites","volume":"11","author":"Badirzadeh","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.intimp.2020.106704_b0295","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.193.6.777","article-title":"The inhibition of arginase by N\u03c9-hydroxy-L-arginine controls the growth of Leishmania inside macrophages","volume":"193","author":"Iniesta","year":"2001","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2020.106704_b0300","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.exppara.2012.01.015","article-title":"The leishmanicidal flavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase","volume":"130","author":"da Silva","year":"2012","journal-title":"Exp. Parasitol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920312121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920312121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:57:59Z","timestamp":1769029079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920312121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":60,"alternative-id":["S1567576920312121"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106704","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential role of nicotinamide on Leishmania tropica: An assessment of inhibitory effect, cytokines gene expression and arginase profiling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106704"}}